Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome

Objective: to evaluate the efficacy of melatonin and clonazepam versus placebo in patients with burning mouth syndrome (BMS). Methods: a prospective double-blind study was carried out in patients with BMS and randomized to three groups: melatonin (1 mg once a day), clonazepam (0.5 mg/twice a day), o...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo-Felipe, Candela, Tvarijonaviciute, Asta, López-Arjona, Marina, Pardo-Marin, Luis, Pons-Fuster, Eduardo, López-Jornet, Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101769/
https://www.ncbi.nlm.nih.gov/pubmed/35566642
http://dx.doi.org/10.3390/jcm11092516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101769/
https://www.ncbi.nlm.nih.gov/pubmed/35566642
http://dx.doi.org/10.3390/jcm11092516

Ejemplares similares